Abstract
Original language | English |
---|---|
Article number | 93 |
Journal | BMC medicine |
Volume | 21 |
Issue number | 1 |
DOIs | |
Publication status | Published - 1 Dec 2023 |
Keywords
- Adverse childhood experiences
- Cardiovascular diseases
- Child abuse
- Childhood maltreatment
- Comorbidity
- Depression
- Depressive disorder
- Diabetes mellitus
- Meta-analysis
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: BMC medicine, Vol. 21, No. 1, 93, 01.12.2023.
Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Depression, cardiometabolic disease, and their co-occurrence after childhood maltreatment
T2 - an individual participant data meta-analysis including over 200,000 participants
AU - Souama, Camille
AU - Lamers, Femke
AU - Milaneschi, Yuri
AU - Vinkers, Christiaan H.
AU - Defina, Serena
AU - Garvert, Linda
AU - Stein, Frederike
AU - Woofenden, Tom
AU - Brosch, Katharina
AU - Dannlowski, Udo
AU - Galenkamp, Henrike
AU - de Graaf, Ron
AU - Jaddoe, Vincent W. V.
AU - Lok, Anja
AU - van Rijn, Bas B.
AU - Völzke, Henry
AU - Cecil, Charlotte A. M.
AU - Felix, Janine F.
AU - Grabe, Hans J.
AU - Kircher, Tilo
AU - on behalf of the EarlyCause consortium
AU - Lekadir, Karim
AU - Have, Margreet ten
AU - Walton, Esther
AU - Penninx, Brenda W. J. H.
N1 - Funding Information: CS coordinated the project administration, analyzed and interpreted cohort-level and aggregate data, and was a major contributor in writing the original manuscript. BP, YM, and FL substantively participated in the supervision and conceptualization and methodology of the project as well as extensively revised the manuscript for critical review. CC, EW, JF, and KL participated in the conceptualization of the research project and monitored progress. SD, LG, FS, and TW substantially contributed to the data analysis of cohorts’ datasets. KL contributed to the acquisition of the financial support for the project leading to this publication. MH and KB contributed to the data curation of cohorts’ datasets. CC, EW, JF, KL, SD, LG, FS, TW, CV, UD, HG, RG, VJ, AL, BR, HV, HG, and TL contributed to the critical revision of the manuscript. All authors read and approved the final manuscript. Funding Information: This study has received funding from the European Union’s Horizon 2020 research and innovation program under Grant Agreement N° 848158 (EarlyCause). In addition, included studies received their own funding. The UK Medical Research Council and Wellcome (Grant ref: 217065/Z/19/Z) and the University of Bristol provide core support for ALSPAC. This publication is the work of the authors, and CS will serve as a guarantor for the contents of this paper. The general design of the Generation R Study is made possible by financial support from the Erasmus MC, Erasmus University Rotterdam, the Netherlands Organization for Health Research and Development and the Ministry of Health, Welfare and Sport. This project received funding from the European Union’s Horizon 2020 research and innovation program (733206, LifeCycle; 874739, LongITools; 874583, ATHLETE; 824989, EUCAN-Connect). HELIUS is conducted by the Amsterdam University Medical Centers, location AMC and the Public Health Service of Amsterdam. Both organizations provided core support for HELIUS. In addition, HELIUS is also funded by the Dutch Heart Foundation (2010T084), the Netherlands Organization for Health Research and Development (ZonMw, 200500003), the European Union (FP-7, 278901), and the European Fund for the Integration of non-EU immigrants (EIF, 2013EIF013). For MACS, Tilo Kircher received unrestricted educational grants from Servier, Janssen, Recordati, Aristo, Otsuka, neuraxpharm. MACS was funded by the German Research Foundation (DFG grant FOR2107, KI588/14–1 and KI588/14–2 to Tilo Kircher, Marburg, Germany; DFG grant DA1151/5–1 and DA1151/5–2 to Udo Dannlowski, Münster, Germany). MIDUS has received funding from John D. and Catherine T. MacArthur foundation Research Network on Successful Midlife Development. NEMESIS-1 is conducted by the Netherlands Institute of Mental Health and Addiction (Trimbos Institute) in Utrecht. Financial support has been received from the Netherlands Ministry of Health, Welfare and Sport (VWS), the Medical Sciences Department of the Netherlands Organization for Scientific Research (NWO), and the National Institute for Public Health and Environment (RIVM). NEMESIS-2 is conducted by the Netherlands Institute of Mental Health and Addiction (Trimbos Institute) in Utrecht. Financial support has been received from the Ministry of Health, Welfare and Sport, with supplementary support from the Netherlands Organization for Health Research and Development (ZonMw) and the Genetic Risk and Outcome of Psychosis (GROUP) investigators. The infrastructure of NESA ( www.nesda.nl ) is funded through the Geestkracht program of the Netherlands Organization for Health Research and Development (Grant No. 10–000-1002) and financial contributions by participating universities and mental health care organizations (VU University Medical Center, GGZ inGeest, Leiden University Medical Center, Leiden University, GGZ Rivierduinen, University Medical Center Groningen, University of Groningen, Lentis, GGZ Friesland, GGZ Drenthe, Dimence, Rob Giel Onderzoekscentrum). The infrastructure for NESDO is funded through the Fonds NutsOhra, Stichting tot Steun VCVGZ, NARSAD The Brain and Behavior Research Fund, and the participating universities and mental health care organizations (VU University Medical Center, Leiden University Medical Center, University Medical Center Groningen, Radboud University Nijmegen Medical Center, and GGZ inGeest, GGZ Nijmegen, GGZ Rivierduinen, Lentis, and Parnassia). The SHIP project is part of the Community Medicine Research Network of the University of Greifswald, Germany, which is funded by the Federal Ministry of Education and Research (grants no. 01ZZ9603, 01ZZ0103, and 01ZZ0403), the Ministry of Cultural Affairs, and the Social Ministry of the Federal State of Mecklenburg-West Pomerania. This study was further supported by the German Research Foundation (GR 1912/5–1, GR 1912/13–1 and grant no. 403694598). UKBB was established by the Wellcome Trust medical charity, Medical Research Council, Department of Health, Scottish Government and the Northwest Regional Development Agency. It has received funding from the Welsh Government, British Heart Foundation, Cancer Research UK and Diabetes UK. It is further supported by the National Health Service and core funding continues to be received from the Wellcome Trust, the Medical Research Council, and, more recently, from Cancer Research UK and NIHR. Publisher Copyright: © 2023, The Author(s).
PY - 2023/12/1
Y1 - 2023/12/1
N2 - Background: Childhood maltreatment is associated with depression and cardiometabolic disease in adulthood. However, the relationships with these two diseases have so far only been evaluated in different samples and with different methodology. Thus, it remains unknown how the effect sizes magnitudes for depression and cardiometabolic disease compare with each other and whether childhood maltreatment is especially associated with the co-occurrence (“comorbidity”) of depression and cardiometabolic disease. This pooled analysis examined the association of childhood maltreatment with depression, cardiometabolic disease, and their comorbidity in adulthood. Methods: We carried out an individual participant data meta-analysis on 13 international observational studies (N = 217,929). Childhood maltreatment comprised self-reports of physical, emotional, and/or sexual abuse before 18 years. Presence of depression was established with clinical interviews or validated symptom scales and presence of cardiometabolic disease with self-reported diagnoses. In included studies, binomial and multinomial logistic regressions estimated sociodemographic-adjusted associations of childhood maltreatment with depression, cardiometabolic disease, and their comorbidity. We then additionally adjusted these associations for lifestyle factors (smoking status, alcohol consumption, and physical activity). Finally, random-effects models were used to pool these estimates across studies and examined differences in associations across sex and maltreatment types. Results: Childhood maltreatment was associated with progressively higher odds of cardiometabolic disease without depression (OR [95% CI] = 1.27 [1.18; 1.37]), depression without cardiometabolic disease (OR [95% CI] = 2.68 [2.39; 3.00]), and comorbidity between both conditions (OR [95% CI] = 3.04 [2.51; 3.68]) in adulthood. Post hoc analyses showed that the association with comorbidity was stronger than with either disease alone, and the association with depression was stronger than with cardiometabolic disease. Associations remained significant after additionally adjusting for lifestyle factors, and were present in both males and females, and for all maltreatment types. Conclusions: This meta-analysis revealed that adults with a history of childhood maltreatment suffer more often from depression and cardiometabolic disease than their non-exposed peers. These adults are also three times more likely to have comorbid depression and cardiometabolic disease. Childhood maltreatment may therefore be a clinically relevant indicator connecting poor mental and somatic health. Future research should investigate the potential benefits of early intervention in individuals with a history of maltreatment on their distal mental and somatic health (PROSPERO CRD42021239288).
AB - Background: Childhood maltreatment is associated with depression and cardiometabolic disease in adulthood. However, the relationships with these two diseases have so far only been evaluated in different samples and with different methodology. Thus, it remains unknown how the effect sizes magnitudes for depression and cardiometabolic disease compare with each other and whether childhood maltreatment is especially associated with the co-occurrence (“comorbidity”) of depression and cardiometabolic disease. This pooled analysis examined the association of childhood maltreatment with depression, cardiometabolic disease, and their comorbidity in adulthood. Methods: We carried out an individual participant data meta-analysis on 13 international observational studies (N = 217,929). Childhood maltreatment comprised self-reports of physical, emotional, and/or sexual abuse before 18 years. Presence of depression was established with clinical interviews or validated symptom scales and presence of cardiometabolic disease with self-reported diagnoses. In included studies, binomial and multinomial logistic regressions estimated sociodemographic-adjusted associations of childhood maltreatment with depression, cardiometabolic disease, and their comorbidity. We then additionally adjusted these associations for lifestyle factors (smoking status, alcohol consumption, and physical activity). Finally, random-effects models were used to pool these estimates across studies and examined differences in associations across sex and maltreatment types. Results: Childhood maltreatment was associated with progressively higher odds of cardiometabolic disease without depression (OR [95% CI] = 1.27 [1.18; 1.37]), depression without cardiometabolic disease (OR [95% CI] = 2.68 [2.39; 3.00]), and comorbidity between both conditions (OR [95% CI] = 3.04 [2.51; 3.68]) in adulthood. Post hoc analyses showed that the association with comorbidity was stronger than with either disease alone, and the association with depression was stronger than with cardiometabolic disease. Associations remained significant after additionally adjusting for lifestyle factors, and were present in both males and females, and for all maltreatment types. Conclusions: This meta-analysis revealed that adults with a history of childhood maltreatment suffer more often from depression and cardiometabolic disease than their non-exposed peers. These adults are also three times more likely to have comorbid depression and cardiometabolic disease. Childhood maltreatment may therefore be a clinically relevant indicator connecting poor mental and somatic health. Future research should investigate the potential benefits of early intervention in individuals with a history of maltreatment on their distal mental and somatic health (PROSPERO CRD42021239288).
KW - Adverse childhood experiences
KW - Cardiovascular diseases
KW - Child abuse
KW - Childhood maltreatment
KW - Comorbidity
KW - Depression
KW - Depressive disorder
KW - Diabetes mellitus
KW - Meta-analysis
UR - http://www.scopus.com/inward/record.url?scp=85150225539&partnerID=8YFLogxK
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85150225539&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/36907864
U2 - https://doi.org/10.1186/s12916-023-02769-y
DO - https://doi.org/10.1186/s12916-023-02769-y
M3 - Article
C2 - 36907864
SN - 1464-2662
VL - 21
JO - BMC medicine
JF - BMC medicine
IS - 1
M1 - 93
ER -